The closing price of BrightSpring Health Services Inc (NASDAQ: BTSG) was $9.26 for the day, down -0.64% from the previous closing price of $9.32. In other words, the price has decreased by -$0.06 from its previous closing price. On the day, 1733604 shares were traded.
Ratios:
Our analysis of BTSG’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.97 and its Current Ratio is at 1.33. In the meantime, Its Debt-to-Equity ratio is 5.98 whereas as Long-Term Debt/Eq ratio is at 5.80.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on February 20, 2024, initiated with a Overweight rating and assigned the stock a target price of $15.
On February 20, 2024, UBS started tracking the stock assigning a Buy rating and target price of $15.
On February 20, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $18.Morgan Stanley initiated its Overweight rating on February 20, 2024, with a $18 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BTSG now has a Market Capitalization of 1.60B and an Enterprise Value of 5.35B. Its current Enterprise Value per Revenue stands at 0.64 whereas that against EBITDA is 17.41.
Stock Price History:
Over the past 52 weeks, BTSG has reached a high of $12.14, while it has fallen to a 52-week low of $9.07. The 50-Day Moving Average of the stock is 10.86, while the 200-Day Moving Average is calculated to be 10.86.
Shares Statistics:
BTSG traded an average of 3.97M shares per day over the past three months and 2.18M shares per day over the past ten days. A total of 171.19M shares are outstanding, with a floating share count of 52.76M. Therefore, it implies a Short% of Shares Outstanding of 5.14% and a Short% of Float of 17.35%.
Earnings Estimates
The firm’s stock currently is rated by 4 analysts. The consensus estimate for the next quarter is $0.06, with high estimates of $0.19 and low estimates of -$0.01.
Analysts are recommending an EPS of between $0.21 and -$1.22 for the fiscal current year, implying an average EPS of -$0.4. EPS for the following year is $0.6, with 9 analysts recommending between $1.23 and $0.33.
Revenue Estimates
Based on 10 analysts’ estimates, the company’s revenue will be $9.44B in the next fiscal year. The high estimate is $9.56B and the low estimate is $9.41B. The average revenue growth estimate for next year is up 7.10% from the average revenue estimate for this year.
